I’m opening with the verdict because the data deserves it. Qualcomm (NASDAQ:QCOM | QCOM Price Prediction) just delivered a Q2 FY26 beat, and our proprietary model now points meaningfully higher from here. Our 24/7…
Earned income demands your time. Dividend income does not. The appeal of a check that arrives every 90 days, regardless of market conditions, is the foundation of every serious passive-income strategy. Real estate offers…
Our ConocoPhillips (NYSE:COP | COP Price Prediction) call comes on the heels of a mixed Q1 2026 earnings report, where adjusted earnings beat but revenue missed amid softer realized prices. Below is the verdict,…
Alphabet (NASDAQ:GOOG | GOOG Price Prediction) just delivered a standout Q1, and our model points to additional upside. After a 9.97% single-day jump on the Q1 print, GOOG now trades at $381.94. Our 24/7…
Altria (NYSE:MO | MO Price Prediction) has staged one of the most surprising rebounds in the consumer defensive sector. After bottoming near $58.19 in November 2025, the stock has ripped back to $72.65, posting…
Our Mastercard (NYSE:MA | MA Price Prediction) thesis is straightforward: the stock has corrected meaningfully in 2026, but the underlying business is accelerating. The 24/7 Wall St. price target for Mastercard is $619.51, implying…
After a brutal year for shareholders, Chipotle Mexican Grill (NYSE:CMG | CMG Price Prediction) just delivered its first quarter of positive transaction growth in over a year. With the stock down 34.46% over the…
The industrial giant has gone on a tear. Caterpillar (NYSE:CAT | CAT Price Prediction) sits at $890.11 after a blowout Q1 2026 earnings report, up 25.88% in the past month and 190.94% over the…
Our Apple (NASDAQ:AAPL | AAPL Price Prediction) call coming out of a blockbuster March quarter is straightforward. The 24/7 Wall St. price target for Apple is $331.17, implying 22.05% upside from the $271.35. Our…
Few stocks have rewritten their narrative as quickly as SanDisk (NASDAQ:SNDK | SNDK Price Prediction). Shares have surged from $32.11 to $1,096.51 over the past year, a gain of 3,314.86%, on structural NAND pricing…
Pfizer (NYSE:PFE | PFE Price Prediction) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on a diversified non-COVID portfolio and a fresh push into obesity…
Amazon delivered a clean earnings report, and our model leans into the strength. Amazon (NASDAQ:AMZN | AMZN Price Prediction) trades at $265.06 after rising 27.27% over the past month, but our proprietary work suggests…
Meta Platforms (NASDAQ:META | META Price Prediction) just delivered one of the strongest quarters in its history, yet the stock sold off hard. That dislocation is exactly where our model finds opportunity. Our 24/7…
I keep buying Eli Lilly (NYSE:LLY | LLY Price Prediction), and the latest quarter just made it harder to stop. This is a confession of conviction. I have been adding through every dip in…
Dividend stocks can be a pillar for long-term investing, generating passive income and offering stability even during tough environments. The current market volatility and geopolitical unrest have attracted investors to dividend stocks. However, not…
Our SoFi Technologies (NASDAQ:SOFI | SOFI Price Prediction) thesis comes down to a simple question: how much should investors pay for a digital bank growing members 35% per year while the market punishes a…
NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) and AMD (NASDAQ:AMD) closed the books on blockbuster quarters. NVIDIA posted $68.13 billion in Q4 FY2026 revenue on 73.21% growth. AMD followed with $10.27B and 34.1% YoY. Both…
I’m coming out of Microsoft’s (NASDAQ:MSFT | MSFT Price Prediction) Q3 FY2026 earnings report with a clear stance: the setup looks compelling at current levels. Microsoft just posted $82.88 billion in revenue, beat EPS…
I keep clicking the buy button on NVIDIA (NASDAQ:NVDA | NVDA Price Prediction), and I know how that sounds at a $5.26 trillion market cap. I am a long-term investor who reads filings on…
Our AstraZeneca (NASDAQ:AZN | AZN Price Prediction) call comes one day after the British drugmaker reported Q1 2026 revenue of $15.29 billion, up 13% year over year, and reaffirmed full-year guidance. With shares at…
